Raymond James Financial Services Advisors’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-287
Closed -$15K 3398
2022
Q1
$15K Hold
287
﹤0.01% 3270
2021
Q4
$13K Sell
287
-12
-4% -$643 ﹤0.01% 3264
2021
Q3
$20K Hold
299
﹤0.01% 3237
2021
Q2
$30K Hold
299
﹤0.01% 3236
2021
Q1
$38K Sell
299
-27
-8% -$3.99K ﹤0.01% 3115
2020
Q4
$36K Sell
326
-6
-2% -$672 ﹤0.01% 2928
2020
Q3
$39K Buy
332
+201
+153% +$34.8K ﹤0.01% 2787
2020
Q2
$28K Hold
131
﹤0.01% 2744
2020
Q1
$29K Sell
131
-34
-21% -$9.69K ﹤0.01% 2348
2019
Q4
$44K Sell
165
-32
-16% -$8.05K ﹤0.01% 2768
2019
Q3
$60K Hold
197
﹤0.01% 2692
2019
Q2
$65K Buy
197
+74
+60% +$37.6K ﹤0.01% 2725
2019
Q1
$77K Hold
123
﹤0.01% 2671
2018
Q4
$30K Sell
123
-14
-10% -$5.57K ﹤0.01% 2497
2018
Q3
$63K Sell
137
-32
-19% -$15.5K ﹤0.01% 2705
2018
Q2
$92K Buy
+169
New +$101K ﹤0.01% 2626
2018
Q1
Sell
-114
Closed -$73K 2698
2017
Q4
$73K Hold
114
﹤0.01% 2410
2017
Q3
$107K Buy
+114
New +$87.2K ﹤0.01% 2387

Other funds holding RMTI

Raymond James Financial Services Advisors's RMTI Position: Q2 2022 in Review

Raymond James Financial Services Advisors sold out of Rockwell Medical (RMTI) in Q2 2022, closing a stake of 287 shares — an estimated $15K sold.

Raymond James Financial Services Advisors first reported a position in RMTI in Q3 2017 and held it in 18 quarters. The position peaked at $107K in Q3 2017. 36 funds tracked by Wall St. Rank hold RMTI as of Q2 2022.

  • Raymond James Financial Services Advisors reported no remaining Rockwell Medical position as of Q2 2022 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 287 Rockwell Medical shares in Q2 2022, an estimated $15K.
  • Raymond James Financial Services Advisors first reported a position in Rockwell Medical in Q3 2017 and held it in 18 quarters.
  • Raymond James Financial Services Advisors's Rockwell Medical position peaked at $107K in Q3 2017.
  • 36 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2022.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.